Who Paid My Doc
BI 764524 Phase 2b
Research payments
$425,990
Through program year 2024, $425,990 in research payments was reported against BI 764524 Phase 2b, across 48 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $425,990 | 48 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Amr Dessouki Campbell, CA Named on 2 payments
- Juner Colina Biscotto Waterford, CT Named on 2 payments
- Margaret Chang Sacramento, CA Named on 2 payments
- Dante Pieramici Santa Barbara, CA Named on 2 payments
- Eric Schneider Nashville, TN Named on 2 payments
- David Liao Los Angeles, CA Named on 2 payments
- Jorge Calzada Southaven, MS Named on 2 payments
- Joel Pearlman Sacramento, CA Named on 2 payments
- Robert Kwun Salt Lake City, UT Named on 2 payments
- Charles Wykoff Bellaire, TX Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.